As of 2025-07-12, the EV/EBITDA ratio of Acutus Medical Inc (AFIB) is -2.09. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Acutus's latest enterprise value is 18.60 mil USD. Acutus's TTM EBITDA according to its financial statements is -8.92 mil USD. Dividing these 2 quantities gives us the above Acutus EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 19.5x - 23.6x | 21.6x |
| Forward P/E multiples | 22.5x - 23.4x | 22.6x |
| Fair Price | (321.16) - 380.25 | 6.76 |
| Upside | -356946.6% - 422403.4% | 7416.2% |
| Date | EV/EBITDA |
| 2025-07-09 | -2.08 |
| 2025-07-07 | -2.08 |
| 2025-06-30 | -2.08 |
| 2025-06-26 | -2.08 |
| 2025-06-25 | -2.08 |
| 2025-06-23 | -2.08 |
| 2025-06-20 | -2.08 |
| 2025-06-17 | -2.08 |
| 2025-06-16 | -2.08 |
| 2025-06-13 | -2.08 |
| 2025-06-12 | -2.08 |
| 2025-06-11 | -2.08 |
| 2025-06-10 | -2.08 |
| 2025-06-09 | -2.08 |
| 2025-06-06 | -2.08 |
| 2025-06-05 | -2.08 |
| 2025-06-04 | -2.08 |
| 2025-06-03 | -2.08 |
| 2025-06-02 | -2.08 |
| 2025-05-29 | -2.08 |
| 2025-05-23 | -2.08 |
| 2025-05-22 | -2.08 |
| 2025-05-21 | -2.08 |
| 2025-05-19 | -2.08 |
| 2025-05-15 | -2.08 |
| 2025-05-14 | -2.08 |
| 2025-05-13 | -2.08 |
| 2025-05-12 | -2.08 |
| 2025-05-09 | -2.08 |
| 2025-05-08 | -2.08 |
| 2025-05-07 | -2.08 |
| 2025-05-05 | -2.08 |
| 2025-05-02 | -2.08 |
| 2025-05-01 | -2.08 |
| 2025-04-30 | -2.08 |
| 2025-04-29 | -2.08 |
| 2025-04-28 | -2.08 |
| 2025-04-25 | -2.08 |
| 2025-04-24 | -2.08 |
| 2025-04-23 | -2.08 |
| 2025-04-22 | -2.08 |
| 2025-04-21 | -2.08 |
| 2025-04-17 | -2.08 |
| 2025-04-16 | -2.08 |
| 2025-04-15 | -2.08 |
| 2025-04-14 | -2.08 |